AstraZeneca investors will look past another strong set of quarterly results on Thursday to focus on the main issue ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in ...

TD Cowen analyst Steve Scala maintained a Hold rating on Pfizer (PFE – Research Report) today and set a price target of $32.00. The company’s ...

A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite ...

In recognition of World Cancer Day 2025, AstraZeneca reaffirms its commitment to advancing early detection, innovative ...

Harvey Jones called on artificial intelligence to help him decide where to invest this year's Stocks and Shares ISA allowance ...

Manchester’s health and life sciences sector is thriving, but as experts at Insider’s roundtable discussed, unlocking its full potential will require greater ...

Vietnam’s pharmaceutical market is expected to have a year of optimism after experiencing a multicoloured gamut in 2024.

Trump's tariffs could derail Europe's 2025 growth, say top Wall Street analysts. Goldman Sachs sees eurozone GDP at 0.7%, ...

Cancer remains one of the leading causes of death globally, with delayed diagnoses and limited access to advanced care significantly contributing to poor outcomes.